Chiesi Farmaceutici to acquire biopharma company Amryt Pharma for $1.5bn

Chiesi Farmaceutici, an Italian biopharmaceuticals and healthcare group, has agreed to acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in an all-cash transaction valued at around ... Read More